Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder

G. Murasaki, Samuel Monroe Cohen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The co-carcinogenic activity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) was evaluated in male Fischer rats by co-administering them as 5% and 0.005% of the diet, respectively, for 2 years. The effect of simultaneous administration of two urinary bladder promoting substances, sodium saccharin and L-tryptophan as 5% and 2% of the diet, respectively, was also evaluated. Five of 16 rats administered sodium saccharin plus FANFT developed bladder tumors whereas none of the rats administered FANFT, sodium saccharin, or L-tryptophan alone, sodium saccharin plus L-tryptophan, or the control diet developed bladder tumors. Possible mechanisms for the co-carcinogenic activity of sodium saccharin and FANFT are discussed.

Original languageEnglish (US)
Pages (from-to)97-99
Number of pages3
JournalCarcinogenesis
Volume4
Issue number1
DOIs
StatePublished - Dec 1 1983

Fingerprint

Saccharin
FANFT
Urinary Bladder
Tryptophan
Diet
Urinary Bladder Neoplasms
Inbred F344 Rats
formamide

ASJC Scopus subject areas

  • Cancer Research

Cite this

Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder. / Murasaki, G.; Cohen, Samuel Monroe.

In: Carcinogenesis, Vol. 4, No. 1, 01.12.1983, p. 97-99.

Research output: Contribution to journalArticle

@article{0b5ff8302c834b6ea367fabed1321d3f,
title = "Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder",
abstract = "The co-carcinogenic activity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) was evaluated in male Fischer rats by co-administering them as 5{\%} and 0.005{\%} of the diet, respectively, for 2 years. The effect of simultaneous administration of two urinary bladder promoting substances, sodium saccharin and L-tryptophan as 5{\%} and 2{\%} of the diet, respectively, was also evaluated. Five of 16 rats administered sodium saccharin plus FANFT developed bladder tumors whereas none of the rats administered FANFT, sodium saccharin, or L-tryptophan alone, sodium saccharin plus L-tryptophan, or the control diet developed bladder tumors. Possible mechanisms for the co-carcinogenic activity of sodium saccharin and FANFT are discussed.",
author = "G. Murasaki and Cohen, {Samuel Monroe}",
year = "1983",
month = "12",
day = "1",
doi = "10.1093/carcin/4.1.97",
language = "English (US)",
volume = "4",
pages = "97--99",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder

AU - Murasaki, G.

AU - Cohen, Samuel Monroe

PY - 1983/12/1

Y1 - 1983/12/1

N2 - The co-carcinogenic activity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) was evaluated in male Fischer rats by co-administering them as 5% and 0.005% of the diet, respectively, for 2 years. The effect of simultaneous administration of two urinary bladder promoting substances, sodium saccharin and L-tryptophan as 5% and 2% of the diet, respectively, was also evaluated. Five of 16 rats administered sodium saccharin plus FANFT developed bladder tumors whereas none of the rats administered FANFT, sodium saccharin, or L-tryptophan alone, sodium saccharin plus L-tryptophan, or the control diet developed bladder tumors. Possible mechanisms for the co-carcinogenic activity of sodium saccharin and FANFT are discussed.

AB - The co-carcinogenic activity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) was evaluated in male Fischer rats by co-administering them as 5% and 0.005% of the diet, respectively, for 2 years. The effect of simultaneous administration of two urinary bladder promoting substances, sodium saccharin and L-tryptophan as 5% and 2% of the diet, respectively, was also evaluated. Five of 16 rats administered sodium saccharin plus FANFT developed bladder tumors whereas none of the rats administered FANFT, sodium saccharin, or L-tryptophan alone, sodium saccharin plus L-tryptophan, or the control diet developed bladder tumors. Possible mechanisms for the co-carcinogenic activity of sodium saccharin and FANFT are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0020561154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020561154&partnerID=8YFLogxK

U2 - 10.1093/carcin/4.1.97

DO - 10.1093/carcin/4.1.97

M3 - Article

C2 - 6821891

AN - SCOPUS:0020561154

VL - 4

SP - 97

EP - 99

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 1

ER -